Any feedback?
Literature summary for 3.4.21.77 extracted from
- Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer (2011), J. Urol., 185, 477-482.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | with prostate specific antigen included in progression criteria, prostate specific antigen at confirmatory biopsy and positive confirmatory biopsy are independent predictors of progression. When prostate specific antigen is excluded from progression criteria, 2- and 5-year progression-free probability is 91% and 76%, respectively. Prostate specific antigen greater than 10 ng/ml was excluded as a criterion | Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| prostate | and prostate cancer tissue | Homo sapiens | - |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
